Molecular analysis and clinical findings in the Spanish Gaucher disease population: Putative haplotype of the N370S ancestral chromosome
Bru Cormand
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona
Search for more papers by this authorDaniel Grinberg
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona
Search for more papers by this authorLaura Gort
Institut de Bioquímica Clínica, Corporació Sanitària Clínic, Barcelona, Spain
Search for more papers by this authorAmparo Chabás
Institut de Bioquímica Clínica, Corporació Sanitària Clínic, Barcelona, Spain
Search for more papers by this authorLluïsa Vilageliu
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona
Search for more papers by this authorBru Cormand
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona
Search for more papers by this authorDaniel Grinberg
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona
Search for more papers by this authorLaura Gort
Institut de Bioquímica Clínica, Corporació Sanitària Clínic, Barcelona, Spain
Search for more papers by this authorAmparo Chabás
Institut de Bioquímica Clínica, Corporació Sanitària Clínic, Barcelona, Spain
Search for more papers by this authorLluïsa Vilageliu
Departament de Genètica, Facultat de Biologia, Universitat de Barcelona
Search for more papers by this authorAbstract
Gaucher disease (GD) is an autosomal recessive disorder caused by mutations in the lysosomal β-glucocerebrosidase (GBA) gene. As the disease is particularly prevalent among Ashkenazi Jews, most studies have been carried out on this ethnic group. In the current study, we present a mutation analysis of the GBA gene in Spanish patients together with the clinical findings. We conducted a systematic analysis in 53 unrelated GD patients. The GBA gene was initially scanned for nine previously described mutations by ASO hybridization or restriction analysis after PCR amplification. The remaining unidentified alleles were screened by nonisotopic PCR-SSCP analysis and sequenced. This approach allowed the identification of 101 of 106 GD alleles (95.3%) involving 24 different mutations, 11 of which are described for the first time: G113E (455G→A), T134P (517A→C), G389E (1283G→A), P391L (1289C→T), N392I (1292A→T), Y412H (1351T→G), W(-4)X (108G→A), Q169X (662C→T), R257X (886C→T), 500insT, and IVS5+1G→T. Most mutations are present in one or few GD chromosomes. However, two mutations, N370S (1226A→G) and L444P (1448T→C), are very frequent and account for 66.1% of the total number of alleles. Linkage disequilibrium was detected between these two mutations and an intragenic polymorphism, indicating that expansion of founder alleles occurred in both cases. Analysis of several microsatellite markers close to the GBA gene allowed us to establish the putative haplotype of the ancestral N370S chromosome. Hum Mutat 11:295–305, 1998. © 1998 Wiley-Liss, Inc.
References
- Abrahamov A, Elstein D, Grosstsur V, Farber B, Glaser Y, Hadashalpern I, Ronen S, Tafakjdi M, Horowitz M, Zimran A (1995) Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet 346: 1000–1003.
-
Amaral O,
Pinto E,
Fortuna M,
Lacerda L,
Miranda M
(1996)
Type 1 Gaucher disease: Identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.
Hum Mutat
8: 280–281.
10.1002/(SICI)1098-1004(1996)8:3<280::AID-HUMU15>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Balicki D, Beutler E (1995) Gaucher disease. Medicine (Baltimore) 74: 305–323.
- Beutler E (1995) Gaucher disease. Adv Genet 32: 17–49.
- Beutler E, Gelbart T (1993) Gaucher disease mutations in non-Jewish patients. Br J Haematol 85: 401–405.
- Beutler E, Gelbart T (1994) Erroneous assignment of Gaucher disease genotype as a consequence of a complete gene deletion. Hum Mutat 4: 212–216.
-
Beutler E,
Gelbart T
(1996)
Glucocerebrosidase (Gaucher disease).
Hum Mutat
8: 207–213.
10.1002/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar
- Beutler E, Gelbart T (1997) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 23: 2–7.
- Beutler E, Grabowski GA (1995) Gaucher disease. In CR Scriver, AL Beaudet, WS Sly, D Valle (eds): The Metabolic and Molecular Bases of Inherited Disease. 7th Ed. New York: McGraw-Hill, pp 2641–2669.
- Beutler E, Demina A, Gelbart T (1994) Glucocerebrosidase mutations in Gaucher disease. Mol Med 1: 82–92.
- Beutler E, West C, Gelbart T (1992b) Polymorphisms in the human glucocerebrosidase gene. Genomics 12: 795–800.
- Chabás A, Cormand B, Balcells S, Gonzàlez-Duarte R, Casanova C, Colomer J, Vilageliu L, Grinberg D (1996) Neuronopathic and non-neuronopathic presentation of Gaucher disease in patients with the third most common mutation (D409H) in Spain. J Inher Metab Dis 19: 798–800.
- Chabás A, Cormand B, Grinberg D, Burguera JM, Balcells S, Merino JL, Mate I, Sobrino JA, González-Duarte R, Vilagelin L (1995) Unusual expression of Gaucher's disease: Cardiovascular calcifications in three sibs homozygous for the D409H mutation. J Med Genet 32: 740–742.
- Chou PY, Fasman GD (1978) Prediction of the secondary structure of proteins from their amino acid sequences. Adv Enzymol 47: 45–158.
- Cormand B, Vilageliu L, Burguera JM, Balcells S, González-Duarte R, Grinberg D, Chabás A (1995) Gaucher disease in Spanish patients: Analysis of eight mutations. Hum Mutat 5: 303–309.
-
Cormand B,
Vilageliu L,
Balcells S,
González-Duarte R,
Chabás A,
Grinberg D
(1996)
Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the betaglucocerebrosidase gene in Gaucher's disease patients.
Hum Mutat
7: 272–274.
10.1002/(SICI)1098-1004(1996)7:3<272::AID-HUMU14>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
-
Cormand B,
Grinberg D,
Gort L,
Fiumara A,
Barone R,
Vilageliu L,
Chabás A
(1997a)
Two new mild homozygous mutations in Gaucher disease patients: Clinical signs and biochemical analyses.
Am J Med Genet
70: 437–443.
10.1002/(SICI)1096-8628(19970627)70:4<437::AID-AJMG19>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Cormand B, Montfort M, Chabás A, Vilageliu L, Grinberg D (1997b) Genetic fine localization of the β-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: Implication for Gaucher disease. Hum Genet 100: 75–79.
- Dahl N, Lagerstrom M, Erikson A, Pettersson U (1990) Gaucher disease Type III (Norrbottnian type) is caused by a single mutation in exon 10 of the glucocerebrosidase gene. Am J Hum Genet 47: 275–278.
- Devereux J, Haeberli P, Smithies O (1984) A comprehensive set of sequences analysis programs for the VAX. Nucleic Acids Res 12: 387–395.
- Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseu P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152–154.
- Fañanás L, Moral P, Panadero MA, Bertranpetit J (1992) Complement genetic markers in schizofrenia: C3, BF and C6 polymorphisms. Hum Hered 42: 162–167.
- Glenn D, Gelbart T, Beutler E (1994) Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes. Hum Genet 93: 635–638.
- Grabowski GA (1993) Gaucher disease—Enzymology, genetics, and treatment. Adv Hum Genet 21: 377–441.
- Grace ME, Graves PN, Smith FI, Grabowski GA (1990) Analyses of catalytic activity and inhibitor binding of human acid β-glucosidase by site-directed mutagenesis. J Biol Chem 265: 6827–6835.
- Grace ME, Newman KM, Scheinker V, Berg-Fussman A, Grabowski GA (1994) Analysis of human acid β-glucosidase by site-directed mutagenesis and heterologous expression. J Biol Chem 269: 2283–2291.
- Grace ME, Desnick RJ, Pastores GM (1997) Identification and expression of acid β-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients. J Clin Invest 99: 2530–2537.
- Guldberg P, Levy HL, Hanley WB, Koch R, Matalon R, Rouse BM, Trefz F, de la Cruz F, Henriksen KF, Guttler F (1996) Phenylalanine hydroxylase gene mutations in the United States: Report from the Maternal PKU Collaborative Study. Am J Hum Genet 59: 84–94.
- Horowitz M, Tzuri G, Eyal N, Berebi A, Kolodny EH, Brady RO, Barton NW, Abrahamou A, Zimran A (1993) Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am J Hum Genet 53: 921–930.
- Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E (1989) The human glucocerebrosidase gene and pseudogene: Structure and evolution. Genomics 4: 87–96.
- Ida H, Iwasawa K, Kawame H, Rennert OM, Maekawa K, Eto Y (1995) Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: Absence of the common Jewish 84GG and 1226G mutations. Hum Genet 95: 717–720.
- Kawame H, Hasegawa Y, Eto Y, Maekawa K (1992) Rapid identification of mutations in the glucocerebrosidase gene of Gaucher disease patients by analysis of single-strand conformation polymorphisms. Hum Genet 90: 294–296.
- Kwok S, Chang S-Y, Sninsky JJ, Wang A (1994) A guide to the design and use of mismatched and degenerated primers. PCR Methods Appl 3: S39–S47.
- Ie Coutre P, Demina A, Beutler E, Beck M, Petrides PE (1997) Molecular analysis of Gaucher disease: distribution of eight mutations and the complete gene deletion in 27 patients from Germany. Hum Genet 99: 816–821.
- Lewis BD, Nelson PV, Robertson EF, Morris CP (1994) Mutation analysis of 28 Gaucher disease patients—The Australasian experience. Am J Med Genet 49: 218–223.
- Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120: 849–852.
- Michelakakis H, Dimitriou E, Vanweely S, Boot RG, Mavridou I, Verhoek M, Aerts J (1995) Characterization of glucocerebrosidase in Greek Gaucher disease patients: Mutation analysis and biochemical studies. J Inher Metab Dis 18: 609–615.
- Miller SA, Dyke DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
- Nelson PV, Carey WF, Morris CP, Lewis BD (1995) Mutation analysis of Australasian Gaucher disease patients. Am J Med Genet 58: 382.
- Ohashi T, Hong CM, Weiler S, Tomich JM, Aerts JMFG, Tager JM, Barranger JA (1991) Characterization of human glucocerebrosidase from different mutant alleles. J Biol Chem 266: 3661–3667.
- Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879.
- Padgett RA, Grabowski PJ, Konarska MM, Seiler S, Sharp PA (1986) Splicing of messenger RNA precursors. Annu Rev Biochem 55: 1119–1150.
- Rice WR (1989) Analyzing tables of statistical test. Evolution 43: 223–225.
- Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA (1993) Phenotype/genotype correlations in Gaucher disease type-I—Clinical and therapeutic implications. Am J Hum Genet 52: 1094–1101.
- Sidransky E, Tsuji S, Martin BM, Stubblefield B, Ginns EI (1992) DNA mutation analysis of Gaucher patients. Am J Med Genet 42: 331–336.
- Sorge J, Gelbart T, West C, Westwood B, Beutler E (1985) Heterogeneity in Type I Gaucher disease demonstrated by restriction mapping of the gene. Proc Natl Acad Sci USA 82: 5442–5445.
- Tylki-Szymanska A, Millat G, Maire I, Czartoryska B (1996) Types I and III Gaucher disease in Poland: Incidence of the most common mutations and phenotypic manifestations. Eur J Hum Genet 4: 334–337.
- Uyama E, Uchino M, Ida H, Eto Y, Owada M (1997) D409H/D409H genotype in Gaucher-like disease. J Med Genet 34: 175.
- Walley AJ, Barth ML, Ellis L, Fensom AH, Harris A (1993) Gaucher's disease in the United Kingdom—Screening non-jewish patients for the two common mutations. J Med Genet 30: 280–283.
- Zimran A, Gelbart T, Beutler E (1990a) Linkage of the sPvu II polymorphism with the common Jewish mutation for Gaucher disease. Am J Hum Genet 46: 902–905.
- Zimran A, Sorge J, Gross E, Kubitz M, West C, Beutler E (1990b) A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. J Clin Invest 85: 219–222.